MY2204-1

Blood: Candida krusei – Shipped April 04, 2022

HISTORY

This challenge was sent as a simulated blood culture sample from a 65 year old patient with cancer. Laboratories were expected to isolate and identify Candida krusei.

MAIN EDUCATIONAL POINTS from MY2204-1

  • Fluconazole is intrinsically resistance and should either reported as resistant or not be reported at all. A comment about intrinsic resistance to fluconazole can provide helpful additional information to the physician.
  • There are currently no clinical breakpoints published for 5-fluorocytosine, itraconazole or posaconazole. Reporting susceptibility results for these agents is inappropriate.

Full critique (PDF)

Posted in critiques, Mycology Results Tagged with: